Chelsea Boyd
Chelsea Boyd is a resident research fellow of harm reduction with the R Street Institute. Her research and writing focuses on decreasing harmful health outcomes for people who engage in high-risk behavior, such as smoking and recreational drug use.
Prior to joining R Street, Chelsea worked for the peer review department at The Patient-Centered Outcomes Research Institute (PCORI). Chelsea’s public health experience also includes serving as a research assistant at the District of Columbia Center for AIDS Research and a laboratory coordinator at Colorado State University’s Arthropod-borne Infectious Diseases Laboratory.
Chelsea holds an M.S. in epidemiology from the George Washington University and a B.A. in interdisciplinary liberal arts with minors in economics and mathematics from Colorado State University.
Carrie Wade & Chelsea Boyd
Dec 11, 2018
The Food and Drug Administration has spoken, and its words have, once again, ruffled many feathers. Coinciding with the deadline for companies to lay out their plans to prevent youth access to e-cigarettes, the agency has announced new regulatory strategies that are sure to not only make it more difficult for young people to access ... Increased e-cigarette regulation increases barriers to health
